Cite
MLA Citation
Susan B. Manoff et al.. “Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults.” Human vaccines & immunotherapeutics, vol. 15, no. 9, 2019, pp. 2195–2204. http://access.bl.uk/ark:/81055/vdc_100113672815.0x000001